Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In this issue

Insight

Close up of a woman taking cough syrup

It's time to change the way we approach coughs in community pharmacySubscription

By

Over-the-counter treatments for the common cough need to be brought up to date and improved, especially considering the social and economic implications of the condition.

Correspondence

Pharmacists’ role in optimising the use of medicines in those with learning disabilitiesSubscription

By

Following on from the response to the Winterbourne View Hospital scandal, where it was discovered many patients suffered serious abuse, the re-evaluation of antipsychotic use in people with learning disabilities has begun, with three separate reports commissioned by NHS England plus a study by Sheehan et al published in The BMJ in September 2015 (

Serious side effect with quinolone antibioticsSubscription

By

A few weeks ago, I found myself in touch with a woman who was clearly unwell, with a lot of intractable peripheral pain, unable to work and unable to live a normal life. The symptoms had been of sudden onset and she associated them with a course of ciprofloxacin that she had been prescribed. The episode began 30 months before and, at the time of writing, is ongoing, with no signs of improvement. I had never heard of such an effect of ciprofloxacin and was initially somewhat sceptical. ...

CPD article

Gastric bypass surgery on obese patient

Bariatric surgery and the effects on drug pharmacokineticsSubscription

By ,

Understanding the types of bariatric surgery, their impact on drug pharmacokinetics and specific recommendations for drug regimens following surgery.

Review

Close up of kidney with renal cell carcinoma

Mammalian target of rapamycin (mTOR) inhibitors in solid tumoursSubscription

By , , ,

The phosphatidylinositol-3-kinase /protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway plays an important role in cell proliferation, growth, and angiogenesis. mTOR is a critical signalling protein as it serves as precursor to many pathways related to cell growth and survival. When this major pathway is dysregulated, it can cause uninhibited activation of cancer cell growth and proliferation. This commonly results in malignancies that affect the kidney, breast and ...

Micrograph of acute myeloid leukaemia (AML)

Current treatments and future targeted treatments for acute myeloid leukaemiaSubscription

By , ,

While the initial therapy for acute myeloid leukaemia (AML) treatment is relatively standardised, the high incidence of refractory/relapsed disease remains a great challenge. Progress has been made in understanding the pathophysiology of both initial and recurrent disease phases, leading to rigorous pre-clinical studies to identify and selectively target cellular pathways that promote leukaemogenesis. In this article, we discuss the ongoing efforts in overcoming relapsed disease, through ...

Pharmaceutical Journal Jobs

More jobs

Clinical Pharmacist

CP March 2016, Vol 8, No 3

Cover Story:

Assessing the evidence for mammalian target of rapamycin inhibition as anticancer therapy in solid malignancies.

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Practice Reports on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.